1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

Novel 1,7- and 2,7-naphthyridine derivatives, designed by the introduction of nitrogen atom into the phenyl ring of previously reported 4-aryl-1-isoquinolinone derivatives, were disclosed as a new structural class of potent and specific PDE5 inhibitors. Among them, 2,7-naphthyridine 4c showed potent PDE5 inhibition (IC(50)=0.23 nM) and one of the best PDE5 specificities against PDEs1-4,6 (>100,000-fold selective versus PDE1-4, 240-fold selective vs PDE6). This compound showed more potent relaxant effects on isolated rabbit corpus cavernosum (EC(30)=5.0 nM) than Sildenafil (EC(30)=8.7 nM). The compound 4c (T-0156) was selected for further biological and pharmacological evaluation of erectile dysfunction.

DOI： 10.1016/s0960-894x(03)00440-2

Knowledge Graph

Similar Paper

1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Novel, Potent, and Selective Phosphodiesterase 5 Inhibitors:  Synthesis and Biological Activities of a Series of 4-Aryl-1-isoquinolinone Derivatives
Journal of Medicinal Chemistry 2001.0
Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives
Bioorganic & Medicinal Chemistry Letters 2005.0
8-(3-Chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0
Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors:  Potential Agents for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2003.0
Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors
Bioorganic & Medicinal Chemistry Letters 2020.0
N-3-Substituted Imidazoquinazolinones:  Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2000.0
Pyrimidinylpyrroloquinolones as Highly Potent and Selective PDE5 Inhibitors for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2002.0
The discovery of novel, potent and selective PDE5 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5
Bioorganic & Medicinal Chemistry 2015.0